What is it used for?
KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) .KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) .
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- selumetinibselumetinib
- Form and strength
- CAPSULE · 10 mg; CAPSULE · 25 mg; GRANULE · 5 mg; GRANULE · 7.5 mgCAPSULE · 10 mg; CAPSULE · 25 mg; GRANULE · 5 mg; GRANULE · 7.5 mg
- Manufacturer / applicant
- ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP
Capsules: •10 mg selumetinib: white to off-white, opaque, hard capsule sealed with a clear band and marked with “SEL 10” in black ink. •25 mg selumetinib: blue, opaque, hard capsule sealed with a clear band and marked with …Capsules: •10 mg selumetinib: white to off-white, opaque, hard capsule sealed with a clear band and marked with “SEL 10” in black ink. •25 mg selumetinib: blue, opaque, hard capsule sealed with a clear band and marked with …
Safety and clinical review
- Left Ventricular DysfunctionLeft Ventricular Dysfunction
- Ocular ToxicityOcular Toxicity
- Gastrointestinal ToxicityGastrointestinal Toxicity
- Skin ToxicitySkin Toxicity
- Increased Creatine PhosphokinaseIncreased Creatine Phosphokinase
- Increased Levels of Vitamin E and Increased Risk of Bleeding (KOSELUGO Capsules)Increased Levels of Vitamin E and Increased Risk of Bleeding (KOSELUGO Capsules)
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is KOSELUGO used for?
KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) .KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN) .
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of KOSELUGO should I ask about?
CAPSULE · 10 mg; CAPSULE · 25 mg; GRANULE · 5 mg; GRANULE · 7.5 mgCAPSULE · 10 mg; CAPSULE · 25 mg; GRANULE · 5 mg; GRANULE · 7.5 mg
Read the primary sourceWhat determines the price of KOSELUGO?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using KOSELUGO?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.